Registered reports present a substantial departure from traditional publishing models with the goal of enhancing the transparency and credibility of the scientific literature. We map the evolving universe of registered reports to assess their growth, implementation and shortcomings at journals across scientific disciplines.
M ost scientists publish research findings within an incentive structure that preferentially values aesthetics over authenticity. Responding to incentives for 'novel' , 'positive' and 'clean' results, researchers may exploit degrees of freedom in the analysis process (knowingly or unknowingly) and opaquely generate or re-calibrate hypotheses post hoc. 'Incremental' , 'negative' or 'messy' findings that cannot be beautified through these questionable (or overtly detrimental) research practices may only be competitive for publication in lower prestige journals, or may not be submitted for publication at all. These selection pressures exerted through the traditional academic publication system may infuse bias into the research process, compromising the credibility of the scientific literature (see Supplementary .
One concept intended to tackle the issues above is 'pre-registration' , the formal archiving of a study protocol (ideally including rationale, hypotheses, methods and proposed analyses) in a public registry before commencement of a study 1, 2 . The rationale is that research is more likely to be comprehensively and transparently reported when researchers can be held accountable to a pre-registered protocol. Questionable research practices such as 'cherry picking' (selectively reporting favourable outcomes), 'P-hacking' (making design and analysis decisions contingent on whether P values are significant) and opaque 'HARKing' (hypothesising after the results are known) can in theory be identified by comparing published research reports to their pre-registered protocols 1 . More broadly, effective pre-registrations may demarcate pre-planned (confirmatory) and post hoc (exploratory) aspects of research, enabling research consumers to make more informed judgements about the validity of scientific results and the credibility of associated claims 3 . Adoption of pre-registration has accelerated recently in several fields with many researchers voluntarily archiving protocols on the Open Science Framework (OSF) 1 . Registration of clinical trials (via ClinicalTrials.gov and other registries) has a longer precedent, with mandatory registration for US researchers introduced in 2005 (ref. ). All these schemes share the goal of increasing transparency, although advocates of pre-registration in the basic and pre-clinical sciences place greater emphasis on detailed specification of analysis plans 1, 3 . Meta-scientific investigations have indicated some potentially beneficial consequences of pre-registration in the context of clinical trials. For example, one study observed that mandatory registration of primary outcomes on ClinicalTrials.gov was associated with a sharp decline in the number of National Heart, Lung, and Blood Institute trials reporting statistically significant results, possibly due to a reduction in selective outcome and analysis reporting 4 . However, other studies have highlighted serious problems, including missing registrations, retrospective registrations, inadequate protocol specification, failure to report results and perpetuation of selective reporting despite registration 2, 5 (also see http://compare-trials.org/).
Recently there has been optimism surrounding a publication format called 'registered reports' which builds on the initiatives outlined above by embedding the pre-registration process directly within the publication pipeline 6, 7 . A registered report involves submitting a study protocol directly to a journal, where it is peer-reviewed and potentially granted in-principle acceptance (IPA) for publication, before the study has even been conducted (Fig. 1) . Publication decisions are therefore based primarily on the quality of the research question and methods, as outlined in the protocol. After study commencement, adherence to the initially accepted protocol (from herein 'IPA protocol') and appropriate calibration of conclusions to findings in the research article (from herein 'final report') is assessed in a second round of peer review. Crucially, this process emphatically does not involve consideration of the aesthetic qualities of the research findings, a substantial departure from traditional publication models.
Registered reports have three unique features that differentiate them from other pre-registration schemes and in theory maximize their intended benefits. First, study protocols are peer-reviewed before commencement, potentially improving research quality through early expert feedback. For example, if reviewers spot a methodological flaw at this stage, the waste of running a poorly designed study can be avoided. Second, studies are granted IPA based solely on the merits of the research question and design, rather than the aesthetic characteristics of the findings, potentially mitigating publication bias. For example, studies granted IPA that observe 'negative' or 'messy' outcomes will still be published, helping to reduce bias towards positive findings in the broader literature. Finally, adherence to the protocol and transparent reporting of protocol deviations is under the close scrutiny of journal editors and reviewers, potentially mitigating selective outcome reporting, cherry picking or opaque HARKing. During the second round of peer review, reviewers who are actively engaged in comparison of the IPA protocol and final report will be more likely to spot these deviations.
Interestingly, in 1997, The Lancet introduced a publication pathway for clinical trials that was similar to registered reports. However, the publication guarantee for new protocols was removed in 2008, and the entire pathway was curtailed in 2015 (see Supplementary Refs 6, 7 ). During its application, it was noted that some trials had deviated substantially from their prespecified outcomes and analyses, and full protocols were not always publicly available 8 . The current instantiation of registered reports was first introduced at the cognitiveneuroscience journal Cortex in March 2013, but it is unclear whether it drew inspiration from The Lancet precedent. Nevertheless, the abandonment of the The Lancet scheme highlights that the in-principle benefits of registered reports cannot be taken for granted. Indeed, it is unlikely that any new policy or innovation designed to improve the validity of scientific findings will be comment perfect the first time around. Iterative evaluation and adjustment may be necessary to ensure that new initiatives are maximally effective and minimally detrimental.
Below we report the findings of an investigation to map the evolving universe of registered reports. Specifically, we sought to record the growth and expansion of this review and publication format across multiple journals and scientific disciplines, the number of registered reports in existence and their status in the publication pipeline, the public availability of information about registered reports (especially access to IPA protocols), methods of protocol registration, the discoverability of final reports, how long it takes for registered reports to be published, and whether they eventually do reach publication. We had no a priori hypotheses about how current registered reports would perform on these dimensions, but simply aimed to explore and describe key aspects of this innovative format and lay the groundwork for future metascientific enquiries.
Growth of registered reports
As of 22 February 2018, the registered report format is still in its nascent stages but has been adopted at a total of 91 journals and begun to expand rapidly across several scientific disciplines (Fig. 2a,b and Supplementary Fig. 2 ). Overall, most registered reports were published in psychology and most were laboratory-based replication studies (see Supplementary Results). A total of 91 final reports had been published as of 22 February 2018, appearing in 16 different journals. Most journals offering registered reports have yet to publish any final reports.
implementation of registered reports
Our initial efforts to identify all existing registered reports ran into problems because of a lack of transparency. It was not straightforward to establish the existence of individual registered reports because many IPA protocols are not publicly available, protocols are not formally registered and final reports are not clearly identified as having been prior registered reports. Ultimately, we were only able to create a partial snapshot of the extant publication pipeline (Supplementary Fig. 3 ). We opted to investigate these issues systematically, extracting data from published final reports where possible, and augmenting this information with responses from a survey of registered reports editors (see Supplementary Methods). Below we document these findings in detail.
We found that many journals have opted to keep IPA protocols 'in house' and consequently a large number of IPA protocols are not publicly available (Fig. 2c,d ). For registered reports that had not yet been published, all IPA protocols that were publicly available were part of The Reproducibility Project in Cancer Biology -published as a special issue in eLife. Some IPA protocols, from Cortex and Royal Society Open Science, were shared with us, but only privately. Both journals indicated that they were planning to change their policy to make protocols publicly available in the future. IPA protocols should be made publicly available to enable verification by the scientific community. When IPA protocols are public, both researchers and journals can be held accountable for their commitment to publish final reports regardless of outcomes. Protocol availability has been promoted for clinical trials in the past several years, allowing assessment of the high frequency of changes in the outcomes and analysis specifications between initial protocols, modified protocols and published papers 5 (http://compare-trials.org/). Even when IPA protocols were publicly available, we often had problems locating and verifying them. We encountered a few cases where protocols were duplicated or missing, and found that over half of published final reports did not clearly identify themselves as registered reports (see Supplementary Results). Journals and authors had also adopted diverse, and apparently sub-optimal, approaches to the registration of IPA protocols. Full registration involves archiving a readonly, time-stamped version of the IPA protocol in an independent registry, such as the OSF. However, of the 74 publicly available IPA protocols, only 26 had been formally registered in this manner. Formal registration ensures that IPA content is persistent and verifiable; enhances discoverability (that is, the protocol appears in searches for pre-registration meta-data); and ensures that protocol deletion results in a formal 'withdrawal notice' so the prior existence of the protocol is publicly acknowledged (https://bit.ly/2Ibropm).
Future directions and recommendations
Our exploration of the registered reports universe has highlighted a number of important implementation issues that could undermine the intended benefits of this review and publication format. Given the rapid expansion of registered reports across journals and scientific disciplines, this is a critical time for developing standards that ensure optimal implementation. The Registered Reports Steering Committee (RR Committee) coordinated by the Center for Open Science (https://cos.io/rr/) currently provides detailed guidelines for journals implementing registered reports. In response to the issues we encountered, the RR Committee has updated its guidance (https://osf.io/pukzy/) to suggest that journals and authors formally and publicly register IPA protocols (C. Chambers, personal communication). However, no author or journal is obligated to conform to their recommendations. Future expansion of the registered reports universe may benefit from the development of a central independent registry to promote standardization. The example of centralized clinical trial registries may offer a useful paradigm in this regard. For example, ClinicalTrials.gov currently contains over 269,900 records 2 with a standardized format for protocol and results reporting. Plans to develop such a central registry based on the OSF are currently underway (https://osf.io/rr/). The RR committee also plans to contact authors who have not yet published IPA protocols and encourage them to make them available in this registry. If authors are concerned about other researchers 'scooping' their ideas, IPA protocols can be registered but then temporarily hidden ('embargoed') until the final report is published (a feature available on the OSF). However, early release of protocols might avoid unnecessary duplication of research effort. An alternative 'partial embargo' system could involve early release of a project summary and embargoed release of the full protocol when the final report is published.
The success of a central registry for registered reports will be dependent on the endorsement and contributions of multiple stakeholders, including policymakers, funders, journals, reviewers and authors. Contributions to ClinicalTrials.gov accelerated when registration was mandated by federal law and an influential consortium of medical journals 2 . However, as highlighted earlier, non-compliance issues remain common, undermining the intended benefits of pre-registration 2, 5 (also see http://compare-trials.org/). A likely contributing factor is that few reviewers appear to actually examine registered protocols 9 . Registered reports may be able to overcome some of these difficulties because of the close oversight built into the unique two-stage peer review process. However, this cannot be taken for granted, and must be carefully monitored.
If the problems we have identified here are adequately addressed, future investigations should have access to sufficient information to examine whether registered reports are living up to expectations on a variety of indices. Such evaluation will be necessary to ensure that registered reports do not provide a false sense of security and their theoretical benefits are actually realized in practice. Future investigations could evaluate the extent to which registered protocols constrain degrees of freedom, how often protocol deviations occur, and whether IPA commitments continue to be honoured by both authors and journals. It also remains to be seen how many registered reports will never get published as final reports and, if so, why they are abandoned. The time frame of the registered reports that we examined here is still too brief (maximum five years since IPA) to conclude that any of these studies have been totally abandoned. However, evidence from medical research suggests that abandonment because of futility or other reasons is common 10 . With these caveats in mind, registered reports seem to be a promising initiative that may improve the transparency, validity and credibility of registered studies. Continuous evaluation of their performance will be helpful to assess whether they meet their goals and how their adoption can be optimized.
reporting Summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
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